Loading...
Programme of the Community Network of Reference Laboratories for Human Influenza to improve Influenza Surveillance in Europe.
Meijer, Adam Brown, Caroline Hungnes, Olav Schweiger, Brunhilde Valette, Martine Werf, Sylvie van der Zambon, Maria
Meijer, Adam
Brown, Caroline
Hungnes, Olav
Schweiger, Brunhilde
Valette, Martine
Werf, Sylvie van der
Zambon, Maria
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2006-11-10
Year of publication
Files
Loading...
meijer.pdf
Adobe PDF, 405.5 KB
Research Projects
Organizational Units
Journal Issue
Title
Programme of the Community Network of Reference Laboratories for Human Influenza to improve Influenza Surveillance in Europe.
Translated Title
Published in
Vaccine 2006; 24(44-46):6717-23
Abstract
All laboratories participating in the Community Network of Reference Laboratories for Human Influenza in Europe (CNRL) co-ordinated by the European Influenza Surveillance Scheme (EISS) should be able to perform a range of influenza diagnostics. This includes direct detection, culture, typing, subtyping and strain characterisation of influenza viruses, diagnostic serology and the creation of archives for clinical specimens and virus isolates. To improve the capacity and quality of the laboratories of the CNRL and to increase the consistency in performance among all 25 European Union countries plus Norway, Romania, and Switzerland, five task groups were set up in February 2005. These task groups developed work programmes in the areas of virus isolation, antibodies, molecular virology, quality control assessment and antiviral susceptibility testing. This report outlines the programmes and the results achieved in the first half-year of operation of the task groups. The action plans are challenging and it is expected that these efforts will lead to considerable improvements in the performance of the laboratories and in the standardisation of methods employed in Europe with regard to routine influenza surveillance and early warning for emerging viruses.